NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.395
+0.065 (4.89%)
At close: Nov 9, 2026, 4:00 PM EST
1.420
+0.025 (1.79%)
Pre-market: Nov 10, 2026, 7:07 AM EST
NervGen Pharma Employees
As of December 31, 2025, NervGen Pharma had 10 total employees, including 9 full-time and 1 part-time employees. The number of employees increased by 3 or 42.86% compared to the previous year. That makes NervGen Pharma the 40,245th largest employer in the world and 6,028th in the United States.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
n/a
Profits / Employee
-$1,565,778
Market Cap
149.99M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2019 | 7 | - | - | 7 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Adagene | 128 |
| Sionna Therapeutics | 59 |
| Protara Therapeutics | 46 |
| Compass Therapeutics | 39 |
| Cue Biopharma | 29 |
| AN2 Therapeutics | 21 |
| Satellos Bioscience | 21 |
NGEN News
- 4 weeks ago - NervGen Pharma doses first participant in RESTORE trial - TheFly
- 5 weeks ago - NervGen Pharma Transcript: R&D Day 2026 - Transcripts
- 5 weeks ago - NervGen Pharma Slides: FY 2026 - Filings
- 6 weeks ago - NervGen Pharma to restate previously filed financial statements - TheFly
- 6 weeks ago - NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments - GlobeNewsWire
- 2 months ago - NervGen to Host Inaugural R&D Day on September 30, 2026 - GlobeNewsWire
- 2 months ago - NervGen Pharma reports Q2 EPS (C$0.37) vs. (C$0.13) last year - TheFly
- 2 months ago - NervGen Pharma Earnings release: Q2 2026 - Filings